Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 31

    1.

    Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

    Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C.

    Diabetologia. 2009 Jul;52(7):1391-9. Epub 2009 May 7.PMID: 19421731 [PubMed - indexed for MEDLINE]Related articles

    2.

    Measurement of CD8 T cell responses in human type 1 diabetes.

    Martinuzzi E, Lemonnier FA, Boitard C, Mallone R.

    Ann N Y Acad Sci. 2008 Dec;1150:61-7. Review.PMID: 19120269 [PubMed - indexed for MEDLINE]Related articles

    3.

    T cells in the pathogenesis of type 1 diabetes.

    Mallone R, van Endert P.

    Curr Diab Rep. 2008 Apr;8(2):101-6. Review.PMID: 18445351 [PubMed - indexed for MEDLINE]Related articles

    4.

    Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.

    Enée E, Martinuzzi E, Blancou P, Bach JM, Mallone R, van Endert P.

    J Immunol. 2008 Apr 15;180(8):5430-8.PMID: 18390725 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.

    Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach JM, Chaillous L, Bruno G, Chatenoud L, van Endert P, Mallone R.

    Diabetes. 2008 May;57(5):1312-20. Epub 2008 Feb 27.PMID: 18305140 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection.

    Martinuzzi E, Scotto M, Enée E, Brezar V, Ribeil JA, van Endert P, Mallone R.

    J Immunol Methods. 2008 Apr 20;333(1-2):61-70. Epub 2008 Jan 29.PMID: 18242633 [PubMed - indexed for MEDLINE]Related articles

    7.

    Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.

    Blancou P, Mallone R, Martinuzzi E, Sévère S, Pogu S, Novelli G, Bruno G, Charbonnel B, Dolz M, Chaillous L, van Endert P, Bach JM.

    J Immunol. 2007 Jun 1;178(11):7458-66.PMID: 17513797 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.

    Mallone R, Martinuzzi E, Blancou P, Novelli G, Afonso G, Dolz M, Bruno G, Chaillous L, Chatenoud L, Bach JM, van Endert P.

    Diabetes. 2007 Mar;56(3):613-21.PMID: 17327428 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    HLA class I epitope discovery in type 1 diabetes.

    van Endert P, Hassainya Y, Lindo V, Bach JM, Blancou P, Lemonnier F, Mallone R.

    Ann N Y Acad Sci. 2006 Oct;1079:190-7.PMID: 17130554 [PubMed - indexed for MEDLINE]Related articles

    10.

    Anti-CD38 autoantibodies in type? diabetes.

    Mallone R, Perin PC.

    Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):284-94. Review.PMID: 16544364 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.

    Mallone R, Nepom GT.

    Am J Ther. 2005 Nov-Dec;12(6):534-50. Review.PMID: 16280647 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Functional avidity directs T-cell fate in autoreactive CD4+ T cells.

    Mallone R, Kochik SA, Reijonen H, Carson B, Ziegler SF, Kwok WW, Nepom GT.

    Blood. 2005 Oct 15;106(8):2798-805. Epub 2005 Jul 19.PMID: 16030184 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes.

    Reijonen H, Mallone R, Heninger AK, Laughlin EM, Kochik SA, Falk B, Kwok WW, Greenbaum C, Nepom GT.

    Diabetes. 2004 Aug;53(8):1987-94.PMID: 15277377 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells.

    Mallone R, Kochik SA, Laughlin EM, Gersuk VH, Reijonen H, Kwok WW, Nepom GT.

    Diabetes. 2004 Apr;53(4):971-7.PMID: 15047612 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete.

    Mallone R, Nepom GT.

    Clin Immunol. 2004 Mar;110(3):232-42. Review.PMID: 15047201 [PubMed - indexed for MEDLINE]Related articles

    16.

    Worsening of hypertension in a pregnant woman with renal arteriovenous malformation: a successful superselective embolization after delivery.

    Allione A, Pomero F, Valpreda S, Porta M, Mallone R, Rabbia C, Cavallo Perin P.

    Clin Nephrol. 2003 Sep;60(3):211-3.PMID: 14524586 [PubMed - indexed for MEDLINE]Related articles

    18.

    Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.

    Mallone R, Ortolan E, Pinach S, Volante M, Zanone MM, Bruno G, Baj G, Lohmann T, Cavallo-Perin P, Malavasi F.

    Diabetologia. 2002 Dec;45(12):1667-77. Epub 2002 Oct 24.PMID: 12488956 [PubMed - indexed for MEDLINE]Related articles

    19.

    Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.

    Chizzolini C, Raschi E, Rezzonico R, Testoni C, Mallone R, Gabrielli A, Facchini A, Del Papa N, Borghi MO, Dayer JM, Meroni PL.

    Arthritis Rheum. 2002 Jun;46(6):1602-13.PMID: 12115192 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects.

    Baj G, Arnulfo A, Deaglio S, Mallone R, Vigone A, De Cesaris MG, Surico N, Malavasi F, Ferrero E.

    Breast Cancer Res Treat. 2002 May;73(1):61-73.PMID: 12083632 [PubMed - indexed for MEDLINE]Related articles

    21.

    Human accessory cells activate fresh, normal, tumor-distant T lymphocytes but not tumor-infiltrating T lymphocytes to lyse autologous tumor cells in a primary cytotoxic T lymphocyte assay in renal cell carcinoma.

    Kramer G, Steiner GE, Paiha S, Handisurya A, Djavan B, Mallone R, Marberger M.

    Eur Urol. 2001 Oct;40(4):427-33.PMID: 11713398 [PubMed - indexed for MEDLINE]Related articles

    22.

    Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes: immunological and genetic characterization.

    Mallone R, Ortolan E, Baj G, Funaro A, Giunti S, Lillaz E, Saccucci F, Cassader M, Cavallo-Perin P, Malavasi F.

    Diabetes. 2001 Apr;50(4):752-62.PMID: 11289039 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Signaling through CD38 induces NK cell activation.

    Mallone R, Funaro A, Zubiaur M, Baj G, Ausiello CM, Tacchetti C, Sancho J, Grossi C, Malavasi F.

    Int Immunol. 2001 Apr;13(4):397-409.PMID: 11282979 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway.

    Deaglio S, Mallone R, Baj G, Donati D, Giraudo G, Corno F, Bruzzone S, Geuna M, Ausiello C, Malavasi F.

    FASEB J. 2001 Mar;15(3):580-2. Epub 2001 Jan 19.PMID: 11259373 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Retinoids in breast cancer prevention and treatment. A review of the literature.

    Baj G, Arnulfo A, Deaglio S, Mallone R, Vigone A, Rosa M, Giana M, Villa L, Malavasi F, Surico N.

    Eur J Gynaecol Oncol. 2000;21(4):411-5. Review.PMID: 11055498 [PubMed - indexed for MEDLINE]Related articles

    26.

    CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes.

    Deaglio S, Mallone R, Baj G, Arnulfo A, Surico N, Dianzani U, Mehta K, Malavasi F.

    Chem Immunol. 2000;75:99-120. Review. No abstract available. PMID: 10851781 [PubMed - indexed for MEDLINE]Related articles

    27.

    CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation.

    Zilber MT, Gregory S, Mallone R, Deaglio S, Malavasi F, Charron D, Gelin C.

    Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2840-5.PMID: 10706632 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    CD38 stimulation lowers the activation threshold and enhances the alloreactivity of cord blood T cells by activating the phosphatidylinositol 3-kinase pathway and inducing CD73 expression.

    Borrione P, Peola S, Mariani S, Besostri B, Mallone R, Malavasi F, Pileri A, Massaia M.

    J Immunol. 1999 May 15;162(10):6238-46.PMID: 10229870 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA.

    Levy Y, Gilburd B, George J, Del Papa N, Mallone R, Damianovich M, Blank M, Radice A, Renaudineau Y, Youinou P, Wiik A, Malavasi F, Meroni PL, Shoenfeld Y.

    Int Immunol. 1998 Jul;10(7):861-8.PMID: 9701024 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia.

    Mallone R, Ferrua S, Morra M, Zocchi E, Mehta K, Notarangelo LD, Malavasi F.

    J Clin Invest. 1998 Jun 15;101(12):2821-30.PMID: 9637716 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member.

    Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzani U, Stockinger H, Malavasi F.

    J Immunol. 1998 Jan 1;160(1):395-402.PMID: 9551996 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...